中国医药
中國醫藥
중국의약
China Medicine
2015年
12期
1798-1800
,共3页
骶骨肿瘤%骶正中动脉%动脉栓塞术,术前
骶骨腫瘤%骶正中動脈%動脈栓塞術,術前
저골종류%저정중동맥%동맥전새술,술전
Sacral tumor%Middle sacral artery%Arterial embolization,preoperative
目的 评估术前动脉栓塞术中行骶正中动脉栓塞对骶骨肿瘤切除术术中出血量的影响.方法 回顾性分析2003年3月至2014年12月125例于肿瘤切除术前行动脉栓塞术的骶骨肿瘤患者,包括47例非巨细胞瘤原发肿瘤、53例巨细胞瘤及25例转移瘤.比较行骶正中动脉栓塞和未行骶正中动脉栓塞者肿瘤切除术术中出血量差异.结果 47例非巨细胞瘤原发肿瘤患者中31例行骶正中动脉栓塞,出血量为1 300(1 000,2 050) ml,16例未行骶正中动脉栓塞,出血量为2 000(1 200,3 400) ml,差异有统计学意义(P =0.04);53例巨细胞瘤患者中35例行骶正中动脉栓塞,出血量为2 000(1 200,3 400) ml,18例未行骶正中动脉栓塞,出血量为2 400(1 500,4 000) ml,差异有统计学意义(P =0.02);25例转移瘤患者中16例行骶正中动脉栓塞,出血量为2025(1 000,3 700) mt,9例未行骶正中动脉栓塞,出血量为1 825(1 175,3 450)ml,差异无统计学意义(P=0.82).结论 骶骨肿瘤尤其是骶骨原发肿瘤切除术前行骶正中动脉栓塞能明显减少术中出血量.
目的 評估術前動脈栓塞術中行骶正中動脈栓塞對骶骨腫瘤切除術術中齣血量的影響.方法 迴顧性分析2003年3月至2014年12月125例于腫瘤切除術前行動脈栓塞術的骶骨腫瘤患者,包括47例非巨細胞瘤原髮腫瘤、53例巨細胞瘤及25例轉移瘤.比較行骶正中動脈栓塞和未行骶正中動脈栓塞者腫瘤切除術術中齣血量差異.結果 47例非巨細胞瘤原髮腫瘤患者中31例行骶正中動脈栓塞,齣血量為1 300(1 000,2 050) ml,16例未行骶正中動脈栓塞,齣血量為2 000(1 200,3 400) ml,差異有統計學意義(P =0.04);53例巨細胞瘤患者中35例行骶正中動脈栓塞,齣血量為2 000(1 200,3 400) ml,18例未行骶正中動脈栓塞,齣血量為2 400(1 500,4 000) ml,差異有統計學意義(P =0.02);25例轉移瘤患者中16例行骶正中動脈栓塞,齣血量為2025(1 000,3 700) mt,9例未行骶正中動脈栓塞,齣血量為1 825(1 175,3 450)ml,差異無統計學意義(P=0.82).結論 骶骨腫瘤尤其是骶骨原髮腫瘤切除術前行骶正中動脈栓塞能明顯減少術中齣血量.
목적 평고술전동맥전새술중행저정중동맥전새대저골종류절제술술중출혈량적영향.방법 회고성분석2003년3월지2014년12월125례우종류절제술전행동맥전새술적저골종류환자,포괄47례비거세포류원발종류、53례거세포류급25례전이류.비교행저정중동맥전새화미행저정중동맥전새자종류절제술술중출혈량차이.결과 47례비거세포류원발종류환자중31례행저정중동맥전새,출혈량위1 300(1 000,2 050) ml,16례미행저정중동맥전새,출혈량위2 000(1 200,3 400) ml,차이유통계학의의(P =0.04);53례거세포류환자중35례행저정중동맥전새,출혈량위2 000(1 200,3 400) ml,18례미행저정중동맥전새,출혈량위2 400(1 500,4 000) ml,차이유통계학의의(P =0.02);25례전이류환자중16례행저정중동맥전새,출혈량위2025(1 000,3 700) mt,9례미행저정중동맥전새,출혈량위1 825(1 175,3 450)ml,차이무통계학의의(P=0.82).결론 저골종류우기시저골원발종류절제술전행저정중동맥전새능명현감소술중출혈량.
Objective To evaluate the influence of preoperative embolization of middle sacral artery on blood loss during excision of sacral tumor.Methods Totally 125 patients with sacral tumor who underwent artery embolization before excision of sacral tumor from March 2003 to December 2014 were retrospectively analyzed.There were 47 cases of primary tumor (non giant cell tumor), 53 cases of giant cell tumor and 25 cases of metastatic tumor.The intraoperative blood loss during excision of sacral tumor was compared between patients with embolization of middle sacral artery and without embolization of middle sacral artery.Results In 47 cases of primary tumor (non giant cell tumor), the middle sacral artery was embolized in 31 cases and not embolized in 16 cases.There was significant difference regarding blood loss during excision of sacral tumor [1 300 (1 000,2 050) ml vs 2 000 (1 200, 3 400) ml] (P =0.04).In 53 cases of giant cell tumor, the middle sacral artery was embolized in 35 cases and not embolized in 18 cases, showing significant difference regarding blood loss during excision of sacral tumor [2000 (1 200, 3 400) ml vs2 400 (1 500, 4000) ml] (P=0.02).In 25 cases metastatic tumor, the middle sacral artery was embolized in 16 cases and not embolized in 9 cases, showing no significant differenceregarding blood loss during excision of sacral tumor [2 025 (1 000, 3 700) ml vs 1 825 (1 175, 3 450) ml] (P =0.82).Conclusion Embolization of middle sacral artery in preoperative embolization can significantly reduce the intraoperative blood loss during excision of sacral tumor, especially sacral primary tumor.
